Intrinsiqs

Is SELLAS Life Sciences Group, Inc. overvalued?

SELLAS Life Sciences Group, Inc. (SLS) — key valuation metrics and fundamentals.

No verdict
Price
$7.86
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$1.59B
Dividend yield
0.0%
Return on equity
-35.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares SLS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.